Clinica Santa Maria

Santiago 7530206

1 studies enrolling now · 8 studies all time

What they study most

Arterial Thrombosis, Arthritis, Rheumatoid, Carcinoma, Non-Small-Cell Lung, First Line Non-Small Cell Lung Cancer, Hip Fractures, Metastatic Renal Cell Carcinoma, Myocardial Injury, Non Small Cell Lung Carcinoma, Non-Small Cell Lung Cancer, Perioperative Bleeding, Renal Cell Carcinoma, Venous Thrombosis

Studies at this site

• HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial — Recruiting now
• PeriOperative ISchemic Evaluation-3 Trial — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• A Study of Bempegaldesleukin (NKTR-214: BEMPEG) in Combination With Nivolumab Compared With the Investigator's Choice of a Tyrosine Kinase Inhibitor (TKI) Therapy (Either Sunitinib or Cabozantinib Monotherapy) for Advanced Metastatic Renal Cell Carcinoma (RCC) — Stopped early
• A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — Completed
• Long-Term Effectiveness And Safety Of CP-690,550 For The Treatment Of Rheumatoid Arthritis — Completed
• Safety and Efficacy of Carboplatin/Paclitaxel and Carboplatin/Paclitaxel/Bevacizumab With and Without Pictilisib in Previously Untreated Advanced or Recurrent Non-small Cell Lung Cancer — Completed
• Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer — Completed